Key statistics
On Monday, Novozymes A/S (0Q4U:LSE) closed at 371.85, 1.54% above its 52-week low of 366.20, set on Feb 25, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 373.35 |
|---|---|
| High | 371.85 |
| Low | 371.85 |
| Bid | 364.30 |
| Offer | 379.40 |
| Previous close | 372.50 |
| Average volume | 296.55k |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.02m |
| P/E (TTM) | 40.27 |
| Market cap | 155.67bn DKK |
| EPS (TTM) | 9.32 DKK |
| Annual div (ADY) | 6.50 DKK |
|---|---|
| Annual div yield (ADY) | 1.74% |
| Div ex-date | Aug 22 2025 |
| Div pay-date | Aug 27 2025 |
| Next div ex-date | Mar 24 2026 |
| Next div pay-date | Mar 26 2026 |
Data delayed at least 20 minutes, as of Mar 02 2026 17:33 GMT.
More ▼
- Trading by management and close relations of management
- Trading by management and close relations of management
- Invitation to the 2026 Annual General Meeting
- Trading by management and close relations of management
- Novonesis delivered strong organic sales growth of 7% in 2025
- Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
- Novonesis' Annual Report 2025
- Trading by management and close relations of management
- Trading by management and close relations of management
- Major shareholder announcement
More ▼
